维生素D补充对肌肉骨骼健康的影响:VITAL与DO-HEALTH试验
本文综述VITAL(n=25 871,5.3年)和DO-HEALTH(n=2 157,3年)试验,评估每日2 000 IU维生素D对一般健康老年人肌肉骨骼结局的影响。两项试验均未发现补充维生素D对非椎体骨折、跌倒、功能下降或衰弱有益。DO-HEALTH中维生素D联合omega-3和家庭运动使 prefrail odds降低39%。
要点
- 每日2 000 IU维生素D未降低非椎体骨折、跌倒、功能下降或衰弱风险。
- VITAL中维生素D未减少总骨折或髋部骨折风险,未改善骨密度或体能。
- DO-HEALTH中三种干预联合使prefrail odds显著降低39%。
核心结论
- 在未预先筛选维生素D缺乏或低骨量/骨质疏松的一般健康且维生素D充足的老年人中,每日2 000 IU维生素D对肌肉骨骼健康无获益。
研究设计与样本
- 本文综述文献并总结VITAL试验(n=25 871,男性≥50岁、女性≥55岁,5.3年)和DO-HEALTH试验(n=2 157,≥70岁,3年)中每日2 000 IU维生素D对肌肉骨骼结局的影响。
主要发现
- 两项试验均发现每日2 000 IU补充维生素D对非椎体骨折、跌倒、功能下降或衰弱无获益。
- VITAL中每日2 000 IU维生素D未降低总骨折或髋部骨折风险。
- VITAL子队列中补充维生素D未改善骨密度或结构(n=771)或体能指标(n=1 054)。
- DO-HEALTH中维生素D联合omega-3和简单家庭运动三种干预联合使prefrail odds较对照显著降低39%。
- VITAL基线平均25(OH)D为30.7±10 ng/mL,DO-HEALTH为22.4±8.0 ng/mL;维生素D治疗组分别增至41.2 ng/mL和37.6 ng/mL。
关键数值与推荐
- VITAL:每日2 000 IU维生素D,5.3年,n=25 871。
- DO-HEALTH:每日2 000 IU维生素D,3年,n=2 157。
- DO-HEALTH三种干预联合使prefrail odds降低39%。
- VITAL基线平均25(OH)D 30.7±10 ng/mL,治疗组增至41.2 ng/mL。
- DO-HEALTH基线平均25(OH)D 22.4±8.0 ng/mL,治疗组增至37.6 ng/mL。
临床怎么用
- 上述发现可能不适用于25(OH)D水平极低、吸收不良性胃肠道疾病或骨质疏松患者。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Previous clinical trials and systematic reviews on the effects of supplemental vitamin D on musculoskeletal outcomes are conflicting. In this paper, we review the literature and summarize the effects of a high daily dose of 2 000 IU vitamin D on musculoskeletal outcomes in generally healthy adults, in men (≥50 years) and women (≥55 years) in the 5.3-year US VITamin D and OmegA-3 TriaL (VITAL) trial (n = 25 871) and women and men (≥70 years) in the 3-year European DO-HEALTH trial (n = 2 157). These studies found no benefit of 2 000 IU/d of supplemental vitamin D on nonvertebral fractures, falls, functional decline, or frailty. In VITAL, supplementation with 2 000 IU/d of vitamin D did not reduce the risk of total or hip fractures. In a subcohort of VITAL, supplemental vitamin D did not improve bone density or structure (n = 771) or physical performance measures (n = 1 054). In DO-HEALTH, which investigated additive benefits of vitamin D with omega-3 and a simple home exercise program, the 3 treatments combined showed a significant 39% decreased odds of becoming prefrail compared to the control. The mean baseline 25(OH)D levels were 30.7 ± 10 ng/mL in VITAL and 22.4 ± 8.0 ng/mL in DO-HEALTH and increased to 41.2 ng/mL and 37.6 ng/mL in the vitamin D treatment groups, respectively. In generally healthy and vitamin D-replete older adults not preselected for vitamin D deficiency or low bone mass or osteoporosis, 2 000 IU/d of vitamin D had no musculoskeletal health benefits. These findings may not apply to individuals with very low 25(OH)D levels, gastrointestinal disorders causing malabsorption, or those with osteoporosis.
引用
- LeBoff MS, Bischoff-Ferrari HA. The Effects of Vitamin D Supplementation on Musculoskeletal Health: The VITAL and DO-Health Trials. J Gerontol A Biol Sci Med Sci. 2023. PMID: 37325962. doi:10.1093/gerona/glad073
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。